Meiji Seika Pharma Co., Ltd.

Quick facts

Marketed products

• Daunorubicin Hydrochloride · Oncology

Phase 3 pipeline

• Matching Vehicle Solution
  Matching Vehicle Solution is a pharmaceutical vehicle or excipient formulation designed to match the properties of an active pharmaceutical ingredient for comparative or control purposes in clinical trials.

Phase 2 pipeline

• ME1111 Solution, High strength
• ME1111 Solution, Low strength

Phase 1 pipeline

• DMB-3111
• DMB-3113
• ME1100 inhalation solution
• ME1111 solution
• OP0595

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Meiji Seika Pharma Co., Ltd. portfolio CI brief
• Meiji Seika Pharma Co., Ltd. pipeline updates RSS